Mucormycosis in India -an in-Depth Postpandemic Review Analysis of Incidence, Prevalence and Management

The emergence of SARS-CoV-2 has increased mucormycosis cases, which was perceived to be a rare infection caused by belligerent fungi belonging to order Mucorales. It is also called the black fungus and is exhibited as one of the seven variants such as rhino-cerebral, cutaneous, pulmonary, renal, gastrointestinal, disseminated or miscellaneous, leading to the debilitation of systemic wellness often associated with a reduction in functional efficiency and characterized by organ failure due to necrosis necessitating early diagnosis and timely treatment. Hence, to sustain the quality of life during the pandemic, a better understanding of mucormycosis is the need of the hour for efficient management to overcome global crises. This review was carried out on existing literature over three decades involving data in India as well as its global comparison, especially in terms of incidence and prevalence for enabling a scientifically evidence-based comprehensive analysis so that appropriate modalities could be adopted in individuals with immunocompromised conditions to safeguard them from contracting as they are more susceptible to having high-risk exposure. Copyright © 2022, Anka Publishers. All rights reserved.

A Rare Presentation of Strongyloides stercoralis Infection from an Immunocompetent Individual in a Tertiary Care Center in South India

Strongyloidiasis is a neglected parasitic disease caused by the intestinal parasite, Strongyloides stercoralis. Most patients with strongyloidiasis are asymptomatic, but few present with varied clinical manifestations such as cutaneous, gastrointestinal, pulmonary, and disseminated disease. It creates a diagnostic dilemma and undue delay in the diagnosis of patients. We report the case of a 79-yearold male who presented with fever and abdominal pain due to strongyloidiasis with no history of immunosuppression. The infection resolved entirely on treatment with ivermectin.